Eyes Unveiled: Revolutionizing the Battle Against Diabetic Retinopathy through Nanotech & AI

SciFocus/June 1, 2024 -- Through this proposed series, we hope to focus on two unparalleled, groundbreaking realms of research: Nanotech and AI, which are individually groundbreaking in their own right but have revolutionized medicinal developments in recent years. This series aims to captivate readers by dissecting the convergence of Nanotech and AI, specifically, towards a chronic disease impairing and damaging millions of lives worldwide, Diabetic Retinopathy.

Diabetic retinopathy (DR) is a common complication of the global epidemic that is Diabetes, with nearly one in six patients suffering from DR facing a threat to their vision. As our understanding of its severity increases, it’s important to simultaneously boost awareness of the rising tools for diagnosis, prognosis, and potential treatment options - AI and Nanotech.

Series Overview:

Our series seeks to distinguish itself by offering a unique exploration of the transformative role that Nanotech and AI play in reshaping our approach to DR. Beyond being individually groundbreaking, the convergence of these two realms opens doors to innovative tools for diagnosis, prognosis, and potential treatment.

Why This Series Matters:

Recent research has expanded our understanding, revealing that DR transcends its microvascular origins to impact the entire neurovascular unit. As our comprehension of the severity of DR broadens, it becomes imperative to raise awareness of the tools at our disposal. This series not only sheds light on the expanding knowledge of DR's effects but also presents AI and Nanotech as dynamic solutions on the frontier of medical advancements.

Engaging the Audience:

We invite readers to join us in uncovering the future of DR management. Whether you are a medical professional, researcher, someone affected by diabetes, or someone curious about the latest scientific breakthroughs, this series promises to deliver insights that resonate with the urgency and potential of the subject matter.

Article 1: "AI Precision in Diabetic Retinopathy: A Singular Fundus Photograph's Diagnostic Aid"

Commonly regarded as an “Underdiagnosed and Undertreated” complication of diabetes, DR is damaging because it tends to go undiscovered by unaware patients. A case study of 300+ patients in Saudi Arabia on reasons behind the late presentation of DR found the biggest factor to be a lack of awareness of the “need for retinal screening.” Already emphasizing the need for an increase in awareness of the disease, case studies on Healthhub, a widely recognized health information platform, have brought to light the consequences of a lack of awareness and delayed diagnosis.?

Through elaborating on case studies, and technological developments, this article aims to highlight the need to adopt a proactive "predict and prevent" attitude when tackling diabetic retinopathy.

The diagnostic prowess of AI Deep learning (DL) models has shown highly impressive results in DR diagnosis and prognosis through the classification of patients’ fundus photographs into categorized DR severities. AI aide not only increases our ability to diagnose but also helps increase patient access as the high efficiency of AI devices no longer requires consultation from ophthalmologists to make a diagnosis, thus allowing screenings to take place in remote areas – the economic implications of the same can come of great use to spreading the treatment and knowledge of Diabetic Retinopathy, as new research has shown that a handheld device by itself can make an accurate assessment; thus, lowering costs of consultation and equipment use.

From the basics of AI and its therapeutic applications to a detailed walkthrough of the Deep Learning models' diagnostic process (essentially explaining how AI can make successful diagnoses with a singular fundus photograph), the article will allow readers to understand the potential of artificial intelligence in medicine. We also aim to explore the scope of the technology through this article- its applications in glaucoma diagnosis, treatment potential, and scope for improvement are all aspects to be discussed that broaden the purpose of the article.

Article 2: "Nanomedicine Breakthroughs in Diabetic Retinopathy: A Comprehensive Arsenal Against Ocular Pathology"

A case study of treatment outcomes of diabetic retinopathy in a diabetic population from Cameroon found <18% of the population to be eligible for their available treatment option, laser photocoagulation. Of that sample, a significant population experienced either worsening or no change post-surgery. This, and countless other cases have made it clear that current screening and treatment methods are limited.

Nanotechnology offers solutions to numerous traditional treatment limitations, addressing issues like poor drug solubility and limited penetrability. Nanomaterials provide sustained drug release and have great potential in aiding and stimulating retinal cell regeneration.

Less-invasive surgeries with a more versatile tool, nanotech can be used in countless forms, each tackling the disease through its unique properties. By exploring various nanomedicine applications (nanoparticles, nanoliposomes, nano scaffolds, etc.), readers will understand nanotech's versatility and the procedures undertaken by medical professionals to tackle DR using nanotech. This refers to gene delivery, drug delivery, retinal cell regeneration, and more. The article will also serve as an update on current progress and clinical trials of nanotech procedures in tackling DR, helping readers acknowledge and anticipate the rise of nanotechnology in medicine.

Author Details:

Sarthak Grover

Sarthak Grover is a biology enthusiast dedicated to inspiring new knowledge and making scientific communication accessible and easy to comprehend for like-minded individuals. He aims to shed light on unique scientific perspectives, exemplified by his current research on the applications of artificial intelligence (AI) in the diagnosis of liver cancer.

Sarthak's research and experience with AI have sparked his curiosity about its wider applications in medicine. AI is a trending and fascinating topic, poised to continue making significant breakthroughs in the medical field, particularly in the areas of diagnosis, treatment, and improving accessibility to healthcare for those in rural regions and those unable to reach public health centres. He believes that communicating these innovations to the general public will motivate further advancements in the field and benefit both researchers and society.

Dr. Shalini Sanyal

Shalini Sanyal, Ph.D. received her Ph.D. from the University of Calcutta (India), where she explored the impact of chronic pesticide exposure on the ocular surface. Her thesis work, conducted under the aegis of the DST-INSPIRE Fellowship, involved collaboration with various stakeholders, including ophthalmologists, farmers, and professionals in the pesticide industry, and earned her the Young Scientist Award in 2019. After graduating, Shalini worked as a SERB-National Postdoctoral Fellow at DBT-inStem (India), where she investigated the suitability of herbal extracts as topical eye drops. Passionate about communicating the latest scientific research to a broader audience, Shalini aims to enhance research dissemination in her current role as an Editor.

If you're enjoying this content, sign up to SciFocus daily newsletter by Biopatrika for all the biggest stories in Science, healthcare, STEM, startups, and how we're advocating to "Bring Science to Society." #SciFocus #Biopatrika

For partnership or advertisement opportunities, feel free to contact us here or visit www.biopatrika.com .

Career Opportunities: Biopatrika Career Hub https://www.dhirubhai.net/groups/13946324/

Follow Virender Singh and Biopatrika on LinkedIn.